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Abstract
Background: West Nile virus (WNV) is transmitted by mosquitoes in both urban as well as in rural environments
and can be pathogenic in birds, horses and humans. Extrinsic factors such as temperature and land use are
determinants of WNV outbreaks in Europe, along with intrinsic factors of the vector and virus.
Methods: With a multivariate model for WNV transmission we computed the probability of WNV infection in
2014, with July 2014 temperature anomalies. We applied the July temperature anomalies under the balanced
A1B climate change scenario (mix of all energy sources, fossil and non-fossil) for 2025 and 2050 to model
and project the risk of WNV infection in the future. Since asymptomatic infections are common in humans
(which can result in the contamination of the donated blood) we estimated the predictive prevalence of
WNV infections in the blood donor population.
Results: External validation of the probability model with 2014 cases indicated good prediction, based on
an Area Under Curve (AUC) of 0.871 (SD = 0.032), on the Receiver Operating Characteristic Curve (ROC). The
climate change projections for 2025 reveal a higher probability of WNV infection particularly at the edges of
the current transmission areas (for example in Eastern Croatia, Northeastern and Northwestern Turkey) and an
even further expansion in 2050. The prevalence of infection in (blood donor) populations in the outbreak-
affected districts is expected to expand in the future.
Conclusions: Predictive modelling of environmental and climatic drivers of WNV can be a valuable tool for
public health practice. It can help delineate districts at risk for future transmission. These areas can be subjected to
integrated disease and vector surveillance, outreach to the public and health care providers, implementation of
personal protective measures, screening of blood donors, and vector abatement activities.
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Background
West Nile virus (WNV) is responsible for large out-
breaks of fatal neuroinvasive disease worldwide [1].
WNV infections occur predominantly through mosquito
bites but also through blood transfusion or organ, tissue
and cell-transplantations. Most human infections are
asymptomatic and mild cases present only flu-like symp-
toms; more severe cases present with signs of encephalitis,
meningo-encephalitis or meningitis. Globally, WNV is a
widespread arthropod-borne virus, an enveloped, single-
strand RNA virus of the genus Flavivirus in the family of
Flaviviridae [2–4]. It circulates in Africa, Americas, Asia,
Europe, and Australia, where it is thought have been
introduced from the Middle East [4]. In Europe, Middle
East and Africa, WNV has been responsible for sporadic
outbreaks in the 1950s in Israel, in the 1960s in Russia
and France, in the 1970s in Belarus, South Africa, and
Ukraine. However, since 1996 it has caused more recur-
rent outbreaks in Europe and northern Africa [5–8]. In
2010, large outbreaks in humans occurred in Southeastern
and Eastern Europe. The European outbreaks occurred in
Russia, the Czech Republic, Hungary, Romania, Turkey,
Greece, Italy, France, Spain and Portugal [9]. Since 2010,
there have been annual outbreaks in Southeastern and
Eastern Europe, suggesting an endemic transmission cycle
and thus a resurgent public health problem [10].
The transmission cycle of WNV is maintained in na-
ture in an enzootic cycle between susceptible birds and
competent ornithophilic mosquitos. A number of intrin-
sic and extrinsic factors are responsible for the complex
nature of WNV epidemiology. Intrinsic factors include
vector and host competence, genetic traits, mosquito
feeding rates and preferences, mosquito longevity and
host immunity [11]. WNV has been detected in over 60
species of mosquitoes but in Europe Culex pipiens seems
to play the most important role [12, 13]. These mosqui-
toes can act as bridge-vectors that feed both on birds as
the principal host as well as on incidental hosts such as
humans and horses. Local birds are responsible for WNV
amplification while infected migratory birds account for
the long-distance dispersion of WNV. The extrinsic fac-
tors include abiotic conditions such as the environmental
settings that shape the transmission dynamic but also
biotic factors such as the density and composition of hosts
and vectors [9].
In Europe, there are sylvatic and synanthropic transmis-
sion scenarios, in rural and urban areas. They respectively
(and independently) contribute to high concentrations of
hosts with competent mosquito vectors that support in-
tense local avian transmission. Rural areas with estuaries,
wetlands or marshes attract migratory birds for breeding,
nesting, and rearing their young. These bird habitats also
attract bird-feeding mosquitoes where congregating bird
populations can get infected with WNV. In fact, a number
of human outbreaks have originated in European estuaries
such as in the Danube delta in Romania, in the Volga delta
in Russia, and in the Rhone delta in France [14]. Urban-
ized areas can also attract large bird and mosquito popula-
tions where humans can get exposed [15]. Moreover,
urban infrastructure can serve as mosquito breeding sites,
such as pools in ineffective drainage systems [16]. For
example, in 1996, a large outbreak occurred in the city of
Bucharest, Romania that affected 4 % of the population
[7]. Over 800 patients were hospitalized during another
large WNV outbreak that occurred in 1999 in Volgograd
City on the west bank of the Great Volga River [17] and in
2010 WNV infections were documented for the first time
in humans in the Greek city of Thessaloniki [18, 19].
Certain metropolitan areas can sustain a high breeding
density of birds; for example, European Starlings thrive on
urban lawns or parks where they can feed, or gulls prolif-
erate near open water [20, 21]. Birds from these types of
urban environments harbour viruses with higher genetic
diversity than birds from residential areas, indicating that
anthropogenic factors associated with urbanization play
an important role in arboviral transmission and evolution
[22]. In the United States, WNV infection rates in crows
and humans are higher in more urbanized environments
that are less forested [23, 24], while in Europe, WNV
transmission can occur both in rural and urban areas.
Ambient temperature is another important environ-
mental determinant in the transmission of WNV as it
has a direct impact on mosquito survival, developmental
rates of immature stages, growth rates of vector popula-
tions and decrease in the interval between blood meals
[25–28]. Moreover, temperature also affects the extrinsic
incubation period (the number of days from ingestion to
transmission) by influencing the viral replication rates
and thus the transmission of WNV [29, 30]. In a model-
ling study elevated air temperature was the strongest
predictor of increased infection in mosquito vectors
[28]. As for Europe, it was found that the unprecedented
upsurge in the number of human WNF cases in the
summer of 2010 was preceded by extremely hot spells in
the region [25]. Moreover, recent research analysed the
status of infection by WNV in Europe and its neighbour-
ing countries in relation to environmental and climatic
risk parameters. The anomalies of temperature in July
were identified as one of the main risk factors [10]. During
recent decades, parts of Europe have warmed up more
than the global average. Additionally, more frequent and
more intense hot extremes have occurred. This trend is
expected to continue while predictions suggest a further
temperature increase (between 1.0 °C and 5.5 °C) by
the end of the century [31]. Increases in ambient
temperature due to climate change are therefore pro-
jected to impact WNV transmission in Europe and its
neighbouring countries [32–36].
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In order to examine these land-use and climatic vari-
ables as predictors of the probability of WNV infection
[4] we tested the contribution of remotely sensed
temperature, the state of vegetation and water bodies,
and bird migratory routes in a statistical model. We also
project the WNV risk in Europe into 2025 and 2050,
with July temperature projections under a balanced
IPCC climate change scenario (A1B) [37]. Among IPCC
scenarios that cover a wide range of the main demo-
graphic, economic, and technological driving forces of
greenhouse gases and sulphur emissions, the A1 scenario
groups are distinguished by their technological emphasis.
A1B represent a balance across all energy sources (inten-
sive fossil and non-fossil energy). Balanced is defined as
not relying too heavily on one particular energy source on
the assumption that similar improvement rates apply to all
energy supply and end use technologies [37].
Insights from these analyses can also be used to assess
the current and future WNV risk to the safety of blood
supply in the region [38]. Thus, we provide a quantification
of the risk of WNV transmission through blood trans-
fusion by estimating the prevalence of infection in
(donor) populations of an area affected by a WNV out-
break, as well as the infection risk of a blood donor that
visited an outbreak affected area. In the long-run, the
environmental determinants identified in this model
lend themselves for an integration of environmental
monitoring in public health surveillance systems of hu-
man cases, serological surveillance of domestic and wild
avifauna, and entomological surveillance [4, 39, 40].
Methods
Temperature data
The association between WNV outbreaks in Europe and
a number of temperature parameters such as mean,
minimum and maximum and their anomalies were ex-
amined by Paz et al. (2013) [25]. Positive temperature
anomalies were found to be a major risk factor for
WNV occurrence. Subsequently, in a study by Tran et
al. (2014) remotely sensed mean temperature anomalies
of July were identified as a risk factor for WNV trans-
mission in Europe [10]. Based on these observations
temperature anomalies were modelled for the present
analysis. Monthly anomalies of July 2014 temperatures
at the locations of WNF outbreaks reported in humans
were computed from NOAA NCEP-NCAR (US National
Centre for Atmospheric Research) database. Predicted
surface temperatures and anomalies were extracted for
2015–2050 climate change A1B scenario, all for the grid-
ded region 30°N-60°N and 10°W-55°E [41]. The pre-
dicted temperatures were based on the Community
Climate System Model (CCSM3) of NCAR, generated
on a Gaussian grid. Following NCAR methodology, the
temperature anomalies data in the current study are
relative to 20th Century Experiment 1980–1999 [36].
The A1B Scenario was chosen since it is a balanced sce-
nario; its main characteristics include: low population
growth, very high GDP growth, very high energy use, low-
medium land use changes, medium resource (mainly oil
and gas) availability, rapid pace and direction of techno-
logical change favouring balanced development. The
chosen model output is the Ensemble Average which is the
mean state of the climate among all model runs. Global cli-
mate simulations were produced at NCAR by the CCSM3
for the 4th Assessment report of the IPCC [42].
WNV epidemiology
The methods for the WNV epidemiological model in
Europe have been described previously [10]. Briefly, the
epidemiologic data of human West Nile cases were ob-
tained from the West Nile fever surveillance conducted
at ECDC during the transmission season in Europe [43].
The transmission season in Europe starts in May and ex-
tends into November. Population data for the European
Union were based on the nomenclature of territorial
units for statistics classification (NUTS) at level 3 with
population estimate of 2010 [44]. Global Administrative
Unit Layers (GAUL) were used for regions outside of
the European Union, and project and population esti-
mates for the year 2010 were derived from the Gridded
Population of the World (GPW) dataset [45].
Environmental variables
To derive the Normalized difference vegetation index
(NDVI) and Modified normalized difference water index
(MNDWI) values, Moderate resolution imaging spectro-
radiometer (MODIS) data products were acquired from
Land Process Distributed Active Archive Center (LP
DAAC). MODIS Terra 8-day composite images of surface
reflectance estimates at 500 m spatial resolution (product
MOD09A1) were acquired for all WNV infected countries
for a twelve years period (2002–2013).
Remotely sensed vegetation indices such as the NDVI
have been identified as risk factors for WNV outbreaks
occurrence in previous North American studies [46, 47].
Indeed, NDVI may serve as an indicator of environmental
conditions suitable for vegetation growth and emergence
of mosquito populations [46]. The presence of water bod-
ies was identified as another environmental WNV risk
factor [47], because large standing water resources may
lead to an upsurge of mosquito populations. The Modified
Normalized Difference Water Index (MNDWI) is particu-
larly suited to the detection of free water [48]. This index
was found to be more appropriate for the analysis than
precipitation due to the inconsistent association between
precipitation and WNV outbreaks [36]. The presence or
absence of wetlands in a district was defined according to
Ramsar Sites Information (https://rsis.ramsar.org/) and
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the Global Lakes and Wetlands Database (GLWD, level
data 1 and 2) (http://www.worldwildlife.org/pages/global-
lakes-and-wetlands-database). Passerine fly ways were dig-
itized in order to categorize administrative units in two
categories of migration flyway (western and eastern) ac-
cording to the migration flyways of Western Palearctic
Passerines South Eastern European bird migration net-
work (http://www.seen-net.eu/).
The long-term average and standard deviation of each
of the environmental indices were computed on monthly
bases for the temperature data, and on 8-days interval
bases for the MODIS NDVI and MNDWI data. The
anomaly (z) of temperatures, NDVI and MNDWI was
calculated for each date i (month or 8-days period) as a
function of the annual indices xi and their long-term
average and standard deviation values. The mean anomal-
ies of temperatures, NDVI and MNDWI were computed
for each district and each month and MODIS 8-days
period. The analysis was performed at the district
level (n = 1113) categorized as ‘infected’ if WNF cases
in humans were reported there that year, and as ‘non-
infected’ otherwise.
Multivariate models
We used multivariate logistic regression models to test
the status of a district as ‘infected’ or ‘not infected’ as
the response variable. Thus, the probability distribution
was assumed to be binomial, and the response variable a
logit function. As explanatory variables we used the
population, the presence of wetlands, the presence of
birds’ migratory routes, the anomalies of temperature,
NDVI and MNDWI as previously described [10]. We
also tested as explanatory variable: the occurrence of a
WNV outbreak the previous year (λ: weighted average of
the number of infected districts amongst the neighbour-
hood the previous year), considering that WNV could
persist locally through survival in overwintering mosqui-
toes or infected birds. A bootstrap procedure (1,000 rep-
licates) was applied to estimate the 95 % confidence
interval (95 % CI) of the parameter estimates, selecting
randomly each time from the original set of 1113 dis-
tricts 90 % of infected districts between 2002 and 2011
(n= 98) and 90 % of non-infected districts (n= 903). The
final model used in the current analysis is described in
Table 1. This model was validated using 2012–2013 epidemi-
ologic data that were not used for model constructions [10].
The average, standard deviation, and anomalies of the
2014 temperature was computed and applied to the model
described above [10]. The results were compared with the
actual occurrence of WNV in 2014. Validity of the model
was assessed based on the ability of the model to distin-
guish between districts with and without WNV, using
sensitivity, specificity, and Area Under Curve (AUC) of
the Receiver Operator Characteristic Curve (ROC).
Climate change projections
The model was used to predict the probability of WNV
infection by applying the projected July temperatures for
2025 and 2050. We extracted gridded temperature projec-
tions for the A1B Scenario, which is a balanced climate
change scenario [42]. July temperature anomalies were en-
tered for each year between 2015 and 2050 in order to
compute the probability of WNV infections per district
and per year which is one of the parameters in the model
(infection the previous year) [10].
Projections of the prevalence of infection
To assess the safety of the blood supply from a WNV in-
fection we used the European Up-Front Risk Assessment
Tool (EUFRAT) developed by ECDC [49]. The risk to
transfusion recipients in outbreak affected regions can
be computed with this tool, quantifying the risk of trans-
mission of emerging pathogens through blood transfu-
sion. The risk can be calculated for any infectious
disease for which a number of characterizing parameters
are known or, as in this study, estimated (i.e. population
size, prevalence, duration of epidemic, proportion of
undetected cases, etc.). We calculated the prevalence of
infection in (donor) population in affected areas and the
probability of the blood donor to become infected after
visiting such an area. For the calculation, the absolute
number of donors infected with WNV in the outbreak-
Table 1 Multivariate logistic regression model parameter of the
risk of WNV infection at district level, EU and neighbouring
countries [10]
Parameter 95 % CI p-value
Intercept −5.85 [−6.02;-5.74] -
TMPJUL 0.37 [0.32;0.41] <10-7
MNDWI21 1.14 [1.06;1.22] <10-15
λ 5.06 [4.78;5.31] <10-15
WETLANDS
1.38 [1.16;1.55] <10-7
Absence
Presence
MIGRATION
1.04 [0.91;1.24] <10-7
Western path
Eastern path
POPULATION 1.66 10-7 [1.66 10-7;2.21 10-7] <10-2
Significant variables are highlighted in bold characters
TMPJUL: Monthly anomalies for July temperature from the perennial mean
monthly temperature
MNDWI21: 8 days anomalies for June Modified Normalized Difference
Water Index
λ: Weighted average of the number of infected districts amongst the
neighbourhood the previous year
Migration: Passerine fly ways were dichotomized into western and eastern
migration flyways according to the migration flyways of Western Palearctic
Passerines South Eastern European bird migration
network (http://www.seen-net.eu/)
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affected area was used from the notification/surveillance
systems reported to ECDC. This number refers to indi-
viduals in the population of the outbreak-affected areas
that are reported/ notified as cases when they seek
health care during the epidemic. We used 60 % as a
conservative estimate of the proportion of undetected
cases which includes WNV infected individuals that may
not develop symptoms, did not seek for health care, or
were misdiagnosed with other diseases and were thus
not reported as cases. The population size was entered
as the population number in the outbreak-affected areas
where the notified cases were recorded. The proportion
of chronic infection was set to zero. The duration of the
epidemic was the length of period since the first case
was reported up until the last day of reported cases and
was set to 300 days. The prevalence of infection in the
(donor) population was calculated based on these pa-
rameters for 2014.
Results
Temperature anomalies in Europe for July 2014 are
shown in Fig. 1. The locations of 210 probable and con-
firmed cases of WNV infections in Europe and neigh-
bouring countries for 2014 are illustrated in Fig. 2. An
affected area was defined as an area with one or more
autochthonous human WNV cases which were recorded
in a number of countries: Austria (1); Greece (15);
Hungary (11); Italy (24); Romania (23); Bosnia and
Herzegovina (13); Israel (17); Palestine (1); Russian
Federation (29); and Serbia (76). We used the multivari-
ate logistic regression model developed by Tran et al.
(2014) to compute the probability of WNV occurrence
based on July temperatures anomalies, the anomaly of
the Modified Normalized Difference Water Index
(MNDWI) in early June, an outbreak of the previous
year, the size of the human population, wetlands and the
type of avian flyways [10]. We applied a standard thresh-
old of 0.5 to classify infected (with probability of infec-
tion greater than 0.5) and non-infected (with probability
of infection lower than 0.5) districts. The probability
map with the July 2014 temperature deviation is pre-
sented in Fig. 3. Geographic areas of predicted probabil-
ity of high WNV infection were North-eastern Greece,
central Hungary, North-eastern Italy, Eastern Romania,
central Serbia, and large areas of Southern Russia. This
probability map was compared with the actual occur-
rence of WNV cases in 2014 (Fig. 2) and a concordance
was observed. Validity of the model was assessed based
on the ability of the model to distinguish between dis-
tricts with and without WNV. External validation of the
model with the 2014 data indicated good prediction
based on the Receiver Operating Characteristic (ROC)
Curve (Fig. 4). The Area Under Curve (AUC) of the
model reached 0.871 (SD = 0.032). Sensitivity was calcu-
lated as the proportion of WNV positive districts cor-
rectly identified by the model and yielded 0.236 (SD =
0.074). Specificity was calculated as the proportion of
WNV negative districts correctly identified by the model
and yielded 0.982 (SD = 0.006).
Probability maps were generated with the A1B
temperature projections (Fig. 5). The results reveal a
progressive expansion of areas with an elevated probability
for WNV infections, particularly at the edges of the trans-
mission areas. For example, the 2025 map reveals a higher
Fig. 1 Temperature anomalies for July 2014
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probability of WNV infection in Northern Serbia, Central
Hungary, North-Eastern Greece, Eastern and Western parts
of Romania and Northwestern Turkey. These are also the
areas that recorded new districts affected by WNV infec-
tions in 2025 compared to 2014 (Fig. 6), which indicates
the expansion of the epidemic. According to this analysis,
total of 81 and 268 new districts recorded WNV infections
for the first time in 2025 and 2050, respectively compared
to 2014 that were situated on the perimeter of the trans-
mission areas. In 2050, the area with a higher probability
will have expanded even more with a total of 147 and 405
districts being affected in 2025 and 2050, respectively.
WNV infections are a significant concern to the safety of
the blood supply, because the blood donated by asymp-
tomatic carriers might inadvertently contaminate the
blood supply [38]. Therefore, we calculated the preva-
lence of infection in (donor) populations in the
outbreak-affected areas. We mapped the donor popula-
tion infectivity (Fig. 7) and found an extended area of
elevated WNV infection hazard for the safety of the
blood supply in 2025 compared to 2014.
Discussion
Projections of WNV risk
The multivariate model for WNV outbreaks developed for
the period 2002 to 2011 and validated with 2012 and 2013
data [10] was applied here to July 2014 temperature
anomalies. The probability map revealed a good agree-
ment with the actual WNV outbreaks in 2014, based on
the ROC curve. Under the A1B climate change scenario
for 2025, this model projects a higher probability of WNV
infection in Northern Serbia, Central Hungary, North-
Eastern Greece, Eastern and Western parts of Romania,
and Northwestern Turkey. These are also the areas where
new districts will be affected by WNV infections.
The ability of the model to detect a district with
WNV infections was moderate (sensitivity = 0.236)
while the ability of the model to correctly detect a
Fig. 2 Districts with probable and confirmed cases of West Nile Virus infections, as of 20/11/2014. Note: An affected area is defined as an area
with one or more autochthonous human WNV cases (neuro-invasive and non neuro-invasive), meeting laboratory criteria as per EU case definition’
(Directive 2008/426/EC). Probable and confirmed: A probable case is any person meeting the clinical criteria AND with at least one of the following
two: − an epidemiological link; − a laboratory test for a probable case. WNV cases by country: Austria (1); Greece (15); Hungary (11); Italy (24); Romania
(23); Bosnia and Herzegovina (13); Israel (17); Palestine (1); Russian Federation (29); and Serbia (76)
Fig. 3 Predicted probability of districts with West Nile Virus infections for 2014
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negative district was very good (specificity = 0.982).
The probability cut off was chose based on public health
grounds. For example, the threshold value obtained using
the observed prevalence method (p = 0.07) would generate
a sensitivity of 0.706 and a specificity of 0.915. Instead we
opted for a higher specificity, which implies (given the
compromise Se/Sp) a low sensitivity. In that sense, our
predictions are rather optimistic. By increasing the sensi-
tivity the number of WNV positive districts would have
increased, potentially “overestimating” the number of
WNV positive districts. The distribution of WNV positive
districts does not follow a Gaussian distribution, but is
skewed to the right. Consequently, a small change in the
threshold would translate into a significant increase in the
number of WNV positive districts even with potentially
few WNV cases per district (It is important to note that
the model predicts the probability for a district to be posi-
tive for WNV, but not the number of cases). In light of
limited resources in public health we chose a more con-
servative approach trying to identify those districts that
are predicted to be truly negative for WNV (high
specificity).
These findings indicate that July temperature anomal-
ies can be used in our prediction model as an early
Fig. 4 Receiver operating characteristic (ROC) curve of the
probability of West Nile Virus infections in 2014
Fig. 5 Predicted probability of districts with West Nile Virus infections based on July temperatures for A1B scenario projections for 2025 (a) and
2050 (b). Note: Among IPCC scenarios, the A1 scenario groups are distinguished by their technological emphasis. A1B represent a balance across
all energy sources (intensive fossil and non-fossil energy)
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warning of the coming WNV season and help delineate
areas of imminent transmission. Positive temperature
anomalies may lead to an upsurge in the growth rates of
vector populations, a decrease in the interval between
blood meals, a shortening of the incubation time in mos-
quitoes, virus evolution rate accelerating and an increase
of the viral transmission efficiency to birds [9, 29, 36].
These areas can then be targeted for enhanced epidemi-
ologic surveillance of neuro-invasive illness (which may
be suggestive of WNV infection), awareness rising
among healthcare workers for the clinical presentation
of WNV infection, and reinforced laboratory diagnostic
capacity. Moreover, these areas can be subjected to ento-
mological surveillance to characterize mosquito breeding
sites, and vector abatement measures to diminish mos-
quito densities. Passive surveillance in domestic birds
and equine populations to monitor the dispersion of
WNV might also be considered.
This model was also applied to July temperature pro-
jections for 2025 and 2050 in order to quantify the
future burden of WNV. These results indicate that 81
and 268 districts will be impacted by WNV outbreaks by
2025 and 2050, respectively. Districts adjacent to dis-
tricts with current transmission are at elevated risk and
should therefore also be considered for the public health
interventions listed above.
Blood supply safety
The arrival and dispersal of tropical pathogens to Europe
and its neighbouring countries commonly associated
with warmer temperatures pose a threat to the supply of
safe blood products, particularly if they are unknown or
without diagnostic tests [38, 50]. Thus, emerging infec-
tious diseases will continue to pose a threat to transfu-
sion safety on European and international levels [51–53].
Specifically, a progressive expansion of areas with an ele-
vated probability for WNV infections will increase the
threat to the safety of blood transfusion. In geographic-
ally larger areas affected by WNV, a higher number of
blood donors will be exposed to infection for a longer
time period (if the duration of the annual mosquito
activity season will be prolonged). Our climate change
projections of the predicted probability of WNV infec-
tion in Europe have far reaching implications for public
health in the future, because the findings in this paper
can contribute to WNV preparedness activities. Besides
the cases of primary WNV infections, secondary infec-
tions through contaminated blood products are of
Fig. 6 New districts affected by West Nile Virus infections in 2025 compared to 2014. Note: Panel a: Confirmed: A confirmed case is any person
meeting laboratory criteria for case confirmation. Panel b: Total (confirmed and probable): A probable case is any person meeting the clinical
criteria AND with at least one of the following two: − an epidemiological link; − a laboratory test for a probable case
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increasing concern to threaten the safety of the blood
supply [38]. The asymptomatic blood-borne phase of a
WNV infection increases the potential for transmission
by transfusion, even if it is relatively short, compared to
Hepatitis B virus or HIV [54]. Moreover, WNV has the
ability to survive and persist in collected blood and
stored blood components and subsequently cause an
infection through the intravenous application. Thus, we
calculated the prevalence of infection in the donor popu-
lations in the outbreak-affected areas (Fig. 7). However,
this instantaneous estimate may underestimate the true
prevalence of infection if the timing of the WNV epidemic
is at the peak of the epidemic curve. Nevertheless, the
map reveals considerable vulnerabilities in Southeastern
Europe when it comes to the safety of the blood supply.
These insights can help transfusion service and clinical
staff identify, manage and plan for transfusion-transmitted
infections. The overall management of blood safety should
be addressed at the institutional level, specifically at regu-
latory agencies or professional organizations [54]. To pre-
serve the number of eligible donors and an adequate
blood supply, authorities will inevitably reassess risk
reduction interventions [38]. These include deferral strat-
egies [55, 56], screening strategies and triggers [57–59],
and also pathogen reduction technologies [38, 60–62].
Moreover, it might be necessary to distribute blood com-
ponents to outbreak areas from unaffected areas in order
to prevent intermittent shortfalls in the blood supply [63].
Such coordination requires supra-national inventories of
blood products that can be dispatched upon demand.
Therefore, the projected temperature change with ele-
vated probability for WNV infections and possible in-
creased prevalence of WNV infected blood donors should
be taken into account in developing preparedness plans
for the WNV safety of the blood supply. This could sub-
stantially increase the costs of blood transfusion therapy.
The projections presented here may therefore offer an
insight into future developments in the risk of transfusion
from WNV infections; it also provides an opportunity to
timely define the optimal strategy of blood safety in the
face of limited available resources.
Limitations
The projections presented in this paper are computed
on the assumption that the other variables remained
stable. For example, the population size was maintained
constant in these projections; however the contribution
of the population size to the model output is very
Fig. 7 Estimated prevalence of West Nile Virus infections in the blood donor population (per 100,000) by districts for 2014 (a) and for 2025 (b).
Note: The prevalence of infection in the (donor) population was calculated based on the European Up-Front Risk Assessment Tool (EUFRAT)
developed by ECDC [49]
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minimal, based on a low parameter value (1.66 10−7).
Moreover, the Eastern bird migration path was retained
in the model, as well as the presence of wetlands, and
the MNDWI21 under the assumption that they will not
change significantly. Yet, other WNV determinants that
were not part of our model could change over the given
time period. For example, mosquito control measures
could differ at the area and country level and change
over time, with implications for WNV incidence. Simi-
larly, the quality of surveillance clinical case detection
might differ too and change over time. WNV might
spread at different rates in local, amplifying bird popula-
tions that might eventually develop herd immunity. More-
over, other environmental determinates might vary over
time as well. We used a statistical approach which involved
modelling the 2002–2013 WNV distribution to assess the
eco-climatic constraints influencing WNV transmission.
The advantage of this statistical approach is that the most
significant temperature and environmental conditions for
determining WNV presence and absence can be identified.
In contrast, biological, mechanistic, or deterministic
models compute the basic reproduction rate (R0) with bio-
logical thresholds relevant to WNV transmission. How-
ever, parameterization of these biological processes
has proven to be difficult; moreover, biological models
do not explicitly model the socioeconomic and public
health contexts in which WNV transmission occurs.
Although there are a number of limitations to our
model, its validation performed rather well based on
the sensitivity and specificity calculations for WNV
infections in 2012, 2013 [10] and 2014.
Conclusion
In several countries of Southeastern Europe, WNV
transmission is now established. Our predictive model
suggests further WNV dispersal in the coming years to
adjacent districts. Monitoring and modelling climatic and
environmental conditions permissive for the inter-
action of migratory birds, resident birds, competent
mosquito vectors and humans can help delineate dis-
tricts at risk of transmission. In light of the rapid pace
of urbanization internationally [64], areas at risk of
current and future WNV transmission can be targeted
for integrated surveillance, vector control measures,
outreach to the public and health care sector, strength-
ened laboratory capacity for reliable WNV diagnosis,
and systematic screening of blood donors [40]. These
activities call for inter-sectorial collaboration to tackle
the challenges of WNV transmission.
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